Extendicare (TSE:EXE) Price Target Raised to C$14.50
Extendicare (TSE:EXE – Free Report) had its price objective hoisted by BMO Capital Markets from C$13.50 to C$14.50 in a research report sent to investors on Monday morning,BayStreet.CA reports. Several other research analysts have also recently weighed in on the company. Cormark upgraded Extendicare to a “moderate buy” rating in a report on Wednesday, February […]
Extendicare (TSE:EXE – Free Report) had its price objective hoisted by BMO Capital Markets from C$13.50 to C$14.50 in a research report sent to investors on Monday morning,BayStreet.CA reports. Several other research analysts have also recently weighed in on the company. Cormark upgraded Extendicare to a “moderate buy” rating in a report on Wednesday, February […]
